Indian Journal of Pharmacy Practice logo
Article

Severe Malaria Due to Vivax: The Underestimated Culprit

1, 1

  1. 1Department of General Medicine, CDSIMER-DSU, Ramanagar, Karnataka, INDIA..

CORRESPONDENCE

Mohammed Imaduddin Mehkri

Department of General Medicine, CDSIMER-DSU, Ramanagar, Karnataka, INDIA..

imadmehkri@gmail.com

Received: 14-08-2024; Accepted: 11-09-2024.

Volume 18, Issue 1 · pp. 122-124 · 2024 · DOI: 10.5530/ijopp.20250093

ABSTRACT

The World Health Organization's (WHO) Southeast Asia Region bears a significant burden of Plasmodium vivax (P. vivax) malaria, accounting for approximately 53% of the global total. Notably, India alone accounted for 47% of this burden in 2018. Historically, P. vivax has been regarded as a relatively benign species, typically causing mild, uncomplicated and self-limiting disease. Plasmodium vivax is known to cause relapsing malaria, but rarely causes severe malaria with cerebral involvement. Only a few cases of cerebral malaria due to P. vivax monoinfection have been reported in the literature. The parasite's preference for attacking reticulocytes in the blood results in lower parasitemia levels, making it potentially undetectable in blood smears and requiring high-level microscopic expertise for accurate diagnosis. It is essential to identify P. vivax infections accurately, as the treatment approach differs due to the higher relapse rate compared to P. falciparum infections. We report a rare case of cerebral malaria caused by mono-infection with Plasmodium vivax in a patient originally from northern India, now residing in rural Bangalore.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Mehkri, M. I., & Arahalli, A. (2024). Severe Malaria Due to Vivax: The Underestimated Culprit. Indian Journal of Pharmacy Practice, 18(1), 122-124. https://doi.org/10.5530/ijopp.20250093

    Copyright and licence

    © 2024 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0